Introduction
Xarelto (Rivaroxaban) is a relatively new anti-coagulant (blood thinner). The Food & Drug Administration (FDA) initially approved Xarelto in July 2011 for use following knee and hip surgery to reduce the risks of deep vein thrombosis (DVT). In November 2011, the FDA approved the drug for additional use as an anti-coagulant in individuals with non-valvular atrial fibrillation.
History of the Case
In November 2012, the FDA extended approval to patients with DVT and pulmonary embolism as well as for long-term treatment to prevent recurrence. Xarelto users sued Johnson & Johnson, Janssen Pharmaceuticals and Bayer Corporation, claiming they suffered from internal bleeding, wound leakage and infections after taking the popular anti-clotting drug. The drug’s makers won six trials but agreed to settle thousands of lawsuits for $775 million in March 2019.
Injuries Related to Product
- Uncontrollable Bleeding
- Wound Infections
- Hepatitis
- Stevens-Johns Syndrome (SJS)
Frequently Asked Questions
What is the status of Xarelto lawsuits?
Thousands of Xarelto lawsuits were filed and many were resolved through a global settlement program. However, claims are still being evaluated, and the litigation landscape continues to evolve. An attorney can assess whether you still have an actionable claim based on your circumstances and jurisdiction.
Who can file a Xarelto lawsuit?
Patients who took Xarelto and experienced a serious bleeding event, as well as family members of patients who died from Xarelto-related complications, may be eligible to file a lawsuit. An attorney can review the specifics of your case, including your medical history and the timing of your injury.
What compensation may be available in a Xarelto lawsuit?
Compensation in Xarelto cases may include medical expenses, lost wages, pain and suffering, and wrongful death damages where applicable. The value of individual claims depends on the severity of injuries and other case-specific factors.
How does Xarelto compare to Eliquis in terms of lawsuits?
Both Xarelto and Eliquis are newer-generation blood thinners, and both have been subject to litigation concerning bleeding risks. The specific claims and litigation history differ between the two drugs. If you took either medication and suffered a serious bleeding event, an attorney can advise you on the legal options applicable to your situation.
